E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if endothelial cells derived from human umbilical
vein are safe for use in conjunction with fistulotomy for the treatment of simple anal
fistulas. Endothelial cells are a special kind of cell in the body that line the inside
surface of blood vessels. The goal of the study is to evaluate the preliminary safety of
human umbilical vein cells in anal fistula healing.